CLS (LON:CLI) Stock Rating Reaffirmed by Peel Hunt

Share on StockTwits

Peel Hunt reissued their buy rating on shares of CLS (LON:CLI) in a research report sent to investors on Wednesday, Stock Target Advisor reports.

Several other equities analysts have also issued reports on the company. Berenberg Bank reaffirmed a buy rating and issued a GBX 275 ($3.59) target price on shares of CLS in a report on Thursday, September 5th. Liberum Capital reaffirmed a buy rating on shares of CLS in a report on Monday, October 14th.

Shares of CLI stock traded up GBX 8 ($0.10) during trading on Wednesday, hitting GBX 256 ($3.35). The company’s stock had a trading volume of 62,607 shares, compared to its average volume of 117,533. The company has a market cap of $1.01 billion and a PE ratio of 7.95. The company has a current ratio of 2.18, a quick ratio of 1.05 and a debt-to-equity ratio of 82.33. The business has a fifty day moving average of GBX 250.04 and a 200-day moving average of GBX 234.20. CLS has a 52 week low of GBX 195 ($2.55) and a 52 week high of GBX 271.50 ($3.55).

In other CLS news, insider Bengt F. Mortstedt sold 322,150 shares of the stock in a transaction on Thursday, October 17th. The stock was sold at an average price of GBX 259 ($3.38), for a total transaction of £834,368.50 ($1,090,250.23). Also, insider Bengt F. Mortstedt sold 172,045 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of GBX 261 ($3.41), for a total value of £449,037.45 ($586,746.96).

About CLS

CLS Holdings plc, together with its subsidiaries, engages in the investment, development, and management of commercial properties in the United Kingdom, France, Germany, and France. It operates in two segments, Investment Property and Other Investments. The company also invests a hotel; and corporate bonds, shares, and other corporate investments.

Featured Article: Growth Stocks

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.